OBX-1201

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOBX-1201

Drug Alias NameMC4 modulator scFv (Obexia)melanocortin-4 receptor modulating single chain variable fragment mAbs (Obexia)scFv-1E8aOBX-1201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionMelanocortin receptor 4 antagonists

TargetsMelanocortin receptor 4

Therapy Area/IndicationsFeeding and Eating DisordersCachexia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesObexia AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesObexia AG

Active IndicationsN/A

Inactive IndicationsFeeding and Eating DisordersCachexia

Other Information

ATC CodeN/A